Article List

WPRIM Management System> DCMS> Clinical and Molecular Hepatology> 2013> 19> 2

Volume: 19 Issue: 2

1. Pseudocirrhosis as a complication after chemotherapy for hepatic metastasis from breast cancer.	Page:190—194
2. beta-catenin activated hepatocellular adenoma.	Page:185—189
3. A case of peripheral gangrene and osteomyelitis secondary to terlipressin therapy in advanced liver disease.	Page:179—184
4. Hepatoid adenocarcinoma of the stomach: an unusual case of elevated alpha-fetoprotein with prior treatment for hepatocellular carcinoma.	Page:173—178
5. Efficacy and safety of entecavir plus carnitine complex (GODEX(R)) compared to entecavir monotherapy in patient with ALT elevated chronic hepatitis B: randomized, multicenter open-label trials. The GOAL study.	Page:165—172
6. The usefulness of transient elastography, acoustic-radiation-force impulse elastography, and real-time elastography for the evaluation of liver fibrosis.	Page:156—164
7. Advanced fibrosis is not a negative pretreatment predictive factor for genotype 2 or 3 chronic hepatitis C patients.	Page:148—155
8. The influence of waist circumference on insulin resistance and nonalcoholic fatty liver disease in apparently healthy Korean adults.	Page:140—147
9. Predictive factors that influence the survival rates in liver cirrhosis patients with spontaneous bacterial peritonitis.	Page:131—139
10. Noninvasive predictors of nonalcoholic steatohepatitis in Korean patients with histologically proven nonalcoholic fatty liver disease.	Page:120—130
11. Noninvasive markers: a double-edged sword that stratifies nonalcoholic steatohepatitis.	Page:116—119
12. Important predictor of mortality in patients with end-stage liver disease.	Page:105—115
13. The lymphatic vascular system in liver diseases: its role in ascites formation.	Page:99—104